Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 81% ± 22% | |
retinal bipolar neuron | 5 studies | 50% ± 25% | |
astrocyte | 4 studies | 46% ± 16% | |
granule cell | 4 studies | 52% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 35% ± 15% | |
glutamatergic neuron | 3 studies | 31% ± 10% | |
endothelial cell | 3 studies | 39% ± 8% | |
interneuron | 3 studies | 36% ± 15% | |
microglial cell | 3 studies | 40% ± 11% | |
OFF-bipolar cell | 3 studies | 34% ± 14% | |
ON-bipolar cell | 3 studies | 57% ± 14% | |
glycinergic amacrine cell | 3 studies | 39% ± 15% | |
rod bipolar cell | 3 studies | 67% ± 16% | |
neuron | 3 studies | 55% ± 30% | |
brush cell | 3 studies | 29% ± 10% | |
GABAergic neuron | 3 studies | 32% ± 6% | |
dendritic cell | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 4184.28 | 2621 / 2642 | 66% | 3.35 | 462 / 705 |
adrenal gland | 7% | 28.26 | 18 / 258 | 63% | 7.32 | 146 / 230 |
pancreas | 34% | 108.70 | 111 / 328 | 25% | 1.54 | 45 / 178 |
stomach | 23% | 69.86 | 83 / 359 | 4% | 0.22 | 12 / 286 |
kidney | 15% | 43.07 | 13 / 89 | 0% | 0.01 | 4 / 901 |
prostate | 0% | 0.91 | 1 / 245 | 7% | 0.28 | 36 / 502 |
intestine | 0% | 1.01 | 4 / 966 | 5% | 0.14 | 25 / 527 |
esophagus | 0% | 0 | 0 / 1445 | 5% | 0.30 | 9 / 183 |
lung | 0% | 0.32 | 1 / 578 | 4% | 0.26 | 49 / 1155 |
bladder | 0% | 0 | 0 / 21 | 3% | 0.16 | 15 / 504 |
liver | 0% | 0 | 0 / 226 | 2% | 0.06 | 8 / 406 |
breast | 1% | 1.66 | 3 / 459 | 1% | 0.05 | 11 / 1118 |
adipose | 2% | 4.70 | 19 / 1204 | 0% | 0 | 0 / 0 |
skin | 1% | 3.21 | 23 / 1809 | 0% | 0.00 | 1 / 472 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.01 | 4 / 459 |
thymus | 0% | 0.74 | 2 / 653 | 0% | 0.01 | 3 / 605 |
ovary | 1% | 1.02 | 1 / 180 | 0% | 0 | 0 / 430 |
blood vessel | 0% | 0.51 | 3 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0070102 | Biological process | interleukin-6-mediated signaling pathway |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_2001269 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ST18 |
Protein name | Suppression of tumorigenicity 18 protein (Zinc finger protein 387) ST18 C2H2C-type zinc finger transcription factor Alternative protein ST18 |
Synonyms | KIAA0535 ZNF387 |
Description | FUNCTION: Repressor that binds to DNA sequences containing a bipartite element consisting of a direct repeat of the sequence 5'-AAAGTTT-3' separated by 2-9 nucleotides. Represses basal transcription activity from target promoters (By similarity). Inhibits colony formation in cultured breast cancer cells. . |
Accessions | E5RFE8 ENST00000521824.5 E5RHS3 O60284 E5RK88 L8E831 ENST00000521582.5 ENST00000522251.5 ENST00000276480.11 ENST00000693301.1 ENST00000699087.1 E5RID0 ENST00000519118.5 E5RHY1 ENST00000689386.1 ENST00000517580.5 |